4,4,5,5-TETRAMETHYL-2-(4-((4-(TRIFLUOROMETHYL)BENZYL)OXY)PHENYL)-1,3,2-DIOXABOROLANE, 95%, 5g

3,6-Bis(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione, 97%, 250mg

3-(Dimethylamino)benzohydrazide, 95.0%, 500mg

D-beta-Homoserine, 95.0%, 1g

3-(3,5-Dimethyl-1h-pyrazol-1-yl)-4h-1,2,4-triazol-4-amine hydrochloride, 97%, 250mg

1-Bromo-3,5-dimethyladamantane>98.0%(GC)25g

3-[2-(Trifluoromethyl)phenyl]propanoic acid, 95.0%, 100g

Methyl 4-fluoro-2,3-dimethoxybenzoate, 98%, 250mg

(1S,2S)-N1,N1-Dimethylcyclohexane-1,2-diamine, 95.0%, 5g

(3-Chloro-5-fluorobenzyl)hydrazine hydrochloride, 97%, 100mg

6-BROMO-7-FLUORO-1H-INDOLE, 95.0%, 250mg

2-(9H-carbazol-9-yl)ethyl methacrylate, 95%, 10g

1-Methyl-1H-benzoimidazol-2-ylamine, 95.0%, 10g